Skip to main content
. Author manuscript; available in PMC: 2009 Apr 9.
Published in final edited form as: Pain. 2008 Aug 19;140(1):23–34. doi: 10.1016/j.pain.2008.07.006

Fig. 1.

Fig. 1

CCD increased the flinch responses evoked by intracutaneous injection of α,β-meATP. The flinching behavior was assessed by determining paw lift time per minute (PLTPM). The maximal flinch responses occurred at 1 min, and responses were completely diminished 10 min after the injection of α,β-meATP (50 nmol). The PLTPM at peak was ~twofold longer in CCD rats (right) than in sham-operated rats (left). The P2X receptor antagonist TNP–ATP (200 nmol) attenuated the flinch responses when co-injected with α,β-meATP. PBS did not produce any significant flinch responses. All rats received a single injection of 50 μl. n = 6 animals for all groups.